Organon & Co | OGN - Capitalización De Mercado





Capitalización De Mercado Cambio Fecha
Bristol-Myers Squibb USD 124.51B 2.96B 2026-10
Celltrion KRW 42.67T 40.86T 2026-10
Cspc Pharmaceutical CNY 103.79B 16.5B 2026-03
Deva Holding AS TRY 17.54B 7.76B 2023-09
Dianthus Therapeutics USD 4.58B 2.8B 2026-03
Divis Laboratories Ltd INR 1.75T 167.78B 2026-06
Gilead Sciences USD 206.51B 21.7B 2026-10
Glaxosmithkline GBP 109.29B 9.36B 2026-03
Kangmei Pharma CNY 16.59B 7.89B 2026-06
Laboratorios Farma EUR 4.17B 917.16M 2026-03
Malin Corporation EUR 133.52M 29.05M 2026-08
Medical Developments International AUD 62.53M 563.29K 2025-12
Merck USD 370.6B 12.1B 2026-10
Neuren Pharmaceuticals AUD 2.36B 606.56M 2025-12
Novartis USD 288.26B 25.18B 2026-03
Organigram Holdings CAD 252.47M 59.69M 2026-03
Organon & Co USD 3.53B 27.08M 2026-10
Ovoca Bio EUR 1.17M 18.38K 2025-12
Pharma Mar EUR 1.31B 263.2M 2026-06
Qiagen NV USD 8.07B 197.36M 2026-06
Sartorius EUR 9.66B 7.77B 2026-10
Zealand Pharma A/S 20.84B 12.51B 2026-03